Article

IntraLase launches fourth-generation laser

San Francisco-IntraLase Corp. introduced itsfourth-generation FS Laser, a system that allows for a 100%blade-free LASIK procedure, according to the company.

San Francisco-IntraLase Corp. introduced its fourth-generation FS Laser, a system that allows for a 100% blade-free LASIK procedure, according to the company.

Doubling the speed of the first laser used to create LASIK corneal flaps reduces the flap procedure time to less than 15 seconds, while maintaining the procedure's excellent safety profile and visual outcomes, the company said in a prepared statement.

"The fourth-generation FS Laser, which comes just 11 months after the introduction of our 30-kHz laser, demonstrates our commitment to the rapid development of our femtosecond technology," said Robert J. Palmisano, president and chief executive officer of IntraLase. "Our commitment to innovation is focused on the fast delivery of the laser's benefits to surgeons and patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.